Results 21 to 30 of about 10,961,826 (306)
Indonesian Biomedical Journal, 2020 BACKGROUND: Carbohydrate antigens 15-3 (CA 15-3) is a conventional tumor marker in breast cancer, with low sensitivity and specificity. MicroRNA (miRNA)-21 showed its stability in circulation and could serve as powerful biomarker.
Merlyna Savitri +8 more
doaj +2 more sources
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. [PDF]
Dis Markers, 2014 CA 15-3, CA 125 and β-2 microglobulin are three common tumor markers currently used for diagnosis, prognosis, assessment of therapeutic response, and/or to evaluate recurrence in breast and ovarian cancer and malignant lymphoproliferative disorders ...
Lucarelli G +11 more
europepmc +2 more sources
AnalyticaA disposable voltammetric immunosensor was developed to measure breast cancer biomarker 15-3 (CA 15-3) in human saliva and serum samples. Screen-printed paper-based electrodes (f-SPE) previously fabricated by our research group using homemade conductive ...
Ana Elisa F. Oliveira +3 more
doaj +2 more sources
International Journal of Biological Markers, 2023 Introduction There is a need for a rapid, accurate, less-invasive approach to distinguishing malignant from benign pleural effusions. We investigated the diagnostic value of five pleural tumor markers in exudative pleural effusions.
Farzaneh Fazli Khalaf +5 more
semanticscholar +1 more source
CA-19-9 as an Emerging Marker of Ovarian Tumour: A Rare Entity [PDF]
Journal of Clinical and Diagnostic Research, 2019 Tumour markers are widely used in clinical practice for diagnosis; follow-up, prognosis and to predict recurrence of certain malignancies. Markers for ovarian cancer include CA-125 antigen, CA-15-3 antigen, and Carcino-Embryonic Antigen (CEA).
Alpana Singh +4 more
doaj +1 more source
Hubungan Kadar Cancer Antigen 15-3 Serum dengan Metastasis Kanker Payudara
Jurnal Ilmu Kesehatan Indonesia, 2021 Background: CA 15-3 serum is one of the tumor marker that has been recommended by American Soviety of Clinical Oncology to show the response of the therapy, prognosis and metastasis of the breast cancer.
Fakhriyyatur Rahmi M +2 more
doaj +1 more source
New Quantum-Dot-Based Fluorescent Immunosensor for Cancer Biomarker Detection
Chemosensors, 2022 Cancer antigen 15-3 (CA 15-3) is a biomarker for breast cancer used to monitor response to treatments and disease recurrence. The present work demonstrates the preparation and application of a fluorescent biosensor for ultrasensitive detection of the ...
Mariana P. Sousa +5 more
doaj +1 more source
Correlation between CA-15-3 and Bone Scan findings in patients with Carcinoma Breast
Asian Pacific Journal of Cancer Biology, 2022 Objectives: Breast cancer is the most common malignant tumor of females; the incidence increases with age. Bone is the most common site to which breast cancer metastasizes.
Julekha Khatun, Tarim Mahmood
doaj +1 more source
Diagnostics, 2023 Tumor marker determinations are valuable tools for the guidance of breast cancer patients during the course of disease. They are assessed on diverse analytical platforms that may be associated with differences according to the methods applied and the ...
Lars Schröder +9 more
doaj +1 more source
Clinical usefulness of cancer markers in primary breast cancer [PDF]
, 2011 The aim of this study was to investigate the diagnostic power of CA 549, MSA and CA 15-3 in identifying breast cancer. The study included 232 patients of which 56 were healthy, 43 had benign breast cancer and 191 with other growths.
Clouth, Aline +3 more
core +2 more sources